SEPN – septerna, inc. (US:NASDAQ)
Stock Stats
News
Septerna (SEPN) had its price target raised by Wells Fargo & Company from $28.00 to $48.00. They now have an "overweight" rating on the stock.
Septerna (SEPN) had its price target raised by HC Wainwright from $35.00 to $40.00. They now have a "buy" rating on the stock.
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy [Yahoo! Finance]
Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of Mast Cell-Driven Diseases, and Outlines Initial Phase 2 Development Strategy
Septerna (SEPN) was upgraded by Zacks Research from "strong sell" to "hold".
Form 4 Septerna, Inc. For: Mar 02 Filed by: Shaikhly Samira
Form 144 Septerna, Inc. Filed by: Shaikhly Samira
Form 8-K Septerna, Inc. For: Mar 01
Form 4 Septerna, Inc. For: Feb 18 Filed by: Bhatt Elizabeth
Form 144 Septerna, Inc. Filed by: Bhatt Elizabeth
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.